Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML